Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator

BACKGROUND: More than 50% of patients undergoing lifelong suppressive antiviral treatment for HIV-1 infection develop minor HIV-1-associated neurocognitive disorders. Neurological complications during HIV-1 infection are the result of direct neuronal damage by proinflammatory products released from...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehla, Rajeev, Bivalkar-Mehla, Shalmali, Nagarkatti, Mitzi, Chauhan, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533742/
https://www.ncbi.nlm.nih.gov/pubmed/23078780
http://dx.doi.org/10.1186/1742-2094-9-239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533742/
https://www.ncbi.nlm.nih.gov/pubmed/23078780
http://dx.doi.org/10.1186/1742-2094-9-239

Ejemplares similares